Figure 3
Demonstrating the effect of dose escalation by dividing patients in to low and high OCT-1 activity groups and then further subdividing them on the basis of ADD received after 12 months.
Demonstrating the effect of dose escalation by dividing patients in to low and high OCT-1 activity groups and then further subdividing them on the basis of ADD received after 12 months.
